Topical therapies in psoriasis

R Torsekar, MM Gautam - Indian dermatology online journal, 2017 - journals.lww.com
Topical therapy as monotherapy is useful in psoriasis patients with mild disease. Topical
agents are also used as adjuvant for moderate-to-severe disease who are being …

Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics

RG Petit, A Cano, A Ortiz, M Espina, J Prat… - International journal of …, 2021 - mdpi.com
Research in the pathogenesis of inflammatory skin diseases, such as skin dermatitis and
psoriasis, has experienced some relevant breakthroughs in recent years. The understanding …

Emollients, moisturizers, and keratolytic agents in psoriasis

JW Fluhr, C Cavallotti, E Berardesca - Clinics in dermatology, 2008 - Elsevier
Emollients, moisturizer, and keratolytic agents are essential in the topical treatment of
psoriasis. They are adjuvants for classic treatments and help to reduce the scale load of the …

Foam-based drug delivery: a newer approach for pharmaceutical dosage form

M Kumar, A Thakur, UK Mandal, A Thakur… - AAPS PharmSciTech, 2022 - Springer
Foam is a dispersal of gas in solid foam or liquid foam. Solid foams are generally formed
through quick curing of liquid foams. Because of their positive characteristics, simplicity of …

[PDF][PDF] Skin care creams: formulation and use

AK Mohiuddin - Dermatol Clin Res, 2019 - soapoilsandherbs.co.za
Skin reflects origin, lifestyle, age and state of health. Skin color, tone and evenness,
pigmentation, as well as skin surface characteristics are signs of skin's health. The cosmetic …

EUPHORBIA CERIFERA CERA (CANDELILA) EMOLLIENT PROPERTIES, USES AND EFFECTIVENESS IN SKINCARE PRODUCTS

E Ekakitie - Journal of Knowledge Learning and Science …, 2024 - jklst.org
Candelila wax, derived from Euphorbia cerifera cera, is a natural and sustainable
component that has a wide range of uses in cosmetic products. This review article explores …

Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis

YK Lin, CJ Chang, YC Chang, WR Wong… - Archives of …, 2008 - jamanetwork.com
Objective To evaluate the efficacy and safety of treatment with indigo naturalis in patients
with recalcitrant plaque-type psoriasis. Design Randomized, observer-blind, vehicle …

Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation

RE Kalb, J Bagel, NJ Korman, MG Lebwohl… - Journal of the American …, 2009 - Elsevier
BACKGROUND: Involvement of areas of the skin fold is common in patients with psoriasis
although the exact incidence is unknown. This report summarizes studies regarding the …

Treatment strategies against psoriasis: principle, perspectives and practices

AK Ramanunny, S Wadhwa, SK Singh… - Current Drug …, 2020 - ingentaconnect.com
Background: Psoriasis is a genetically predisposed autoimmune disease mediated by
cytokines released by the activated immune cells. It manifests inflammatory, scaly red or …

1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study

A Kreuter, A Sommer, J Hyun, M Bräutigam… - Archives of …, 2006 - jamanetwork.com
Objective During the last decades, management of intertriginous psoriasis (IP) has been
unsatisfactory because of the adverse effects associated with long-term corticosteroid …